Have a personal or library account? Click to login
Factors Influencing Pharmacokinetic/Pharmacodynamic Index of Meropenem in Critically Ill Patients Cover

Factors Influencing Pharmacokinetic/Pharmacodynamic Index of Meropenem in Critically Ill Patients

Open Access
|Feb 2026

Figures & Tables

Basic socio-demographic and clinical characteristics of recruited patients

VaraibleMean ± standard deviation (range) or number (%)
Gender (M/F)37 (58.7%) / 26 (41.3%)
Age (years)63.92±1.62
Body weight (kg)78.46±12.73
Charlson comorbidity index4.25±2.66
Hypertension20 (31.7%)
Chronic renal insufficiency8 (12.7%)
Cerebral infarction11 (17.5%)

The most common causes of infections in our patients

BacteriaNumber (%)
Klebsiella spp.17 (27%)
Staphylococcus aureus12 (19%)
Proteus mirabilis12 (19%)
Acinetobacter spp.9 (14.3%)
Pseudomonas aeruginosa6 (9.5%)
Enterobacter4 (6.3%)
Escherichia coli3 (4.8%)

Crude and adjusted odds ratios (OR) of the risk factors for meropenem underdosing in critically ill patients

Risk factorsUnivariate model Crude OR with 95% CI pMultivariate model Adjusted OR with 95% CI p
Gender5.037 (1.188–21.359) p=0.028*4.505 (0.562–36.087) p=0.156
Age1.004 (0.954–1.057) p=0.8780.988 (0.891–1.095) p=0.818
Acinetobacter spp.3.778 (1.942–6.725) p=0.000*4.637 (1.365–14.961) p=0.000*
Pseudomonas aeruginosa1.812 (1.147–5.125) p=0.044*2.938 (1.392–7.116) p=0.035*
Pneumonia1.286 (0.329–5.021) p=0.7184.945 (0.393–62.148) p=0.216
Urinary tract infection0.600 (0.142–2.532) p=0.4870.676 (0.075–6.088) p=0.727
DOI: https://doi.org/10.2478/eabr-2025-0016 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 245 - 250
Submitted on: Aug 1, 2025
|
Accepted on: Aug 15, 2025
|
Published on: Feb 23, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Milos N. Milosavljevic, Aleksandar Rancic, Slobodan Jankovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.